LXW7 TFA, a cyclic peptide containing Arg-Gly-Asp (RGD), is an integrin alphavbeta3 inhibitor. LXW7 has a high binding affinity to alphavbeta3 integrin with an IC50 of 0.68 µM. LXW7 TFA increases phosphorylation of VEGFR-2 and activation of ERK1/2. Anti-inflammatory effect[1][2][3].
Molecular Weight:
934.92
Purity:
98.44
Formula:
C31H49F3N12O14S2
Target:
Integrin
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
